Agents affecting the digestive system and metabolism
Name | Dosage form | ATC code |
---|---|---|
Alpha-tocopherol acetate (vitamin E) Alpha-tocopherol acetate (vitamin E) 50 mg/ml, 20 ml № 1 Oral oil solution Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
50 mg/ml, 20 ml № 1 | A11HA03 |
Alpha-tocopherol acetate (vitamin E) Alpha-tocopherol acetate (vitamin E) 100 mg/ml, 20 ml № 1 Oral oil solution Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
100 mg/ml, 20 ml № 1 | A11HA03 |
Alpha-tocopherol acetate (vitamin E) Alpha-tocopherol acetate (vitamin E) 300 mg/ml, 20 ml № 1 Oral oil solution Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
300 mg/ml, 20 ml № 1 | A11HA03 |
Aquavit-D3 Aquavit-D3 375 mcg/ml, 10 ml № 1 Oral solution Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
375 mcg/ml, 10 ml № 1 | A11CC05 |
Ascorbic acid Ascorbic acid 50 mg № 50 Dragee Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
50 mg № 50 | A11GA01 |
Ascorbic acid Ascorbic acid 50 mg/ml, 2 ml № 10, № 100 Solution for injections Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
50 mg/ml, 2 ml № 10, № 100 | A11GA01 |
Ascorbic acid Ascorbic acid 100 mg/ml, 2 ml № 10, № 100 Solution for injections Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
100 mg/ml, 2 ml № 10, № 100 | A11GA01 |
Ascorbic acid Ascorbic acid 25 mg №50 Tablets Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
25 mg №50 | A11GA01 |
Ascorbic acid Ascorbic acid 25 mg № 100 Tablets Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
25 mg № 100 | A11GA01 |
Bisacodyl Bisacodyl 0,01 g № 10 Rectal suppositories Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
0,01 g № 10 | A06AB02 |
Carbacid Pechaevskiy Carbacid Pechaevskiy № 20 Chewable tablets Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
№ 20 | A02AX |
Dalmaxin Dalmaxin 0,2 g № 5, № 10 Suppositories Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
0,2 g № 5, № 10 | A05BA |
Diosmectite Diosmectite 3,0 g №10 Powder for oral solution Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
3,0 g №10 | A07BC05 |
Ergocalciferol (vitamin D2) Ergocalciferol (vitamin D2) 0,125 %, 10 ml № 1 Oral oil solution Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
0,125 %, 10 ml № 1 | A11CC01 |
Glibenclamide Glibenclamide 5 mg № 30 Tablets Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
5 mg № 30 | А10ВВ01 |
Heksavit Heksavit № 50 Dragee Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
№ 50 | A11BA |
Kreazim 10000 Kreazim 10000 № 20 Hard capsules Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
№ 20 | A09AA02 |
Kreazim 20000 Kreazim 20000 № 20 Hard capsules Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
№ 20 | A09AA02 |
Lactulose Lactulose 670 mg/ml 100 ml Syrup Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
670 mg/ml 100 ml | A06AD11 |
Lactulose Lactulose 670 mg/ml 200 ml Syrup Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
670 mg/ml 200 ml | A06AD11 |
Lekplex | 2 ml № 5 | А11DВ |
Leksadyl Leksadyl 10 mg № 10 Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
10 mg № 10 | А06АВ02 |
Lektac Lektac 150 mg № 10, № 20, № 30 Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
150 mg № 10, № 20, № 30 | A02BA02 |
Loperamide Loperamide 0,002 g № 10, № 20 Tablets Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
0,002 g № 10, № 20 | A07DA03 |
Methovitan Methovitan 20 hard capsules Hard capsules Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
20 hard capsules | А11АВ |
Methyluracil Methyluracil 0,5 g, № 5 ,№ 10 Rectal suppositories Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
0,5 g, № 5 ,№ 10 | A14B |
Nevrolek Nevrolek 2 ml № 5 Solution for injections Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
2 ml № 5 | A11DB |
No-H-Sha No-H-Sha 0,04 g № 10, № 30 Tablets Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
0,04 g № 10, № 30 | A03A D02 |
No-H-Sha No-H-Sha 20 mg/mg, 2 ml in ampoules № 5 Solution for injections Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
20 mg/mg, 2 ml in ampoules № 5 | A03AD02 |
No-H-Sha No-H-Sha 0,04 g № 10 Rectal suppositories Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
0,04 g № 10 | A03AD02 |
No-H-Sha forte No-H-Sha forte 0,08 g № 30 Tablets Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
0,08 g № 30 | A03AD02 |
Ondansetron Ondansetron 4 mg № 10 Film-coated tablets Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
4 mg № 10 | A04AA01 |
Ondansetron Ondansetron 8 mg № 10 Film-coated tablets Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
8 mg № 10 | A04AA01 |
Ondansetron Ondansetron 2 mg/ml 2 ml № 5 Solution for injections Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
2 mg/ml 2 ml № 5 | A04AA01 |
Ondansetron Ondansetron 2 mg/ml 4 ml № 5 Solution for injections Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
2 mg/ml 4 ml № 5 | A04AA01 |
Pancreatin 8000 Pancreatin 8000 № 20, №50 Enterosoluble tablets Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
№ 20, №50 | A09AA02 |
Pancreazim Pancreazim № 20, № 50 Enterosoluble tablets Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
№ 20, № 50 | A09AA02 |
Pancreazim 10000 Pancreazim 10000 № 20, № 50 Enterosoluble tablets Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
№ 20, № 50 | А09АА02 |
Pancreazim 10000 Pancreazim 10000 № 20, № 50 Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
№ 20, № 50 | А09АА02 |
Papaverine Papaverine 20 mg/ml, 2 ml № 10 Solution for injections Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
20 mg/ml, 2 ml № 10 | A03AD01 |
Pyridoxine hydrochloride (vitamin В6) Pyridoxine hydrochloride (vitamin В6) 50 mg/ml, 1 ml № 10 Solution for injections Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
50 mg/ml, 1 ml № 10 | A11HA02 |
Ranitidine Ranitidine 150 mg № 20 Film-coated tablets Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
150 mg № 20 | A02BA02 |
Ranitidine Ranitidine 150 mg №30 Film-coated tablets Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
150 mg №30 | A02BA02 |
Renalgan Renalgan 5 ml №5 Solution for injections Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
5 ml №5 | A03DA02 |
Renalgan Renalgan № 10 Tablets Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
№ 10 | A03DA02 |
Renalgan Renalgan 2 ml №10 Solution for injections Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
2 ml №10 | A03DA02 |
Renalgan Renalgan №20 Tablets Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
№20 | A03DA02 |
Retinol acetate (vitamin A) Retinol acetate (vitamin A) 34,4 mg/ml, 10 ml № 1 Oral oil solution Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
34,4 mg/ml, 10 ml № 1 | A11CA01 |
Revit Revit № 75, № 100 Dragee Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
№ 75, № 100 | A11BA |
Solizym forte Solizym forte № 20 Enterosoluble tablets Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
№ 20 | A09AA |
Stomolik Stomolik 125 ml № 1 Solution for oral cavity Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
125 ml № 1 | А01АВ12 |
Thiamine chloride (vitamin В1) Thiamine chloride (vitamin В1) 50 mg/ml, 1 ml in ampoules № 10 Solution for injections Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
50 mg/ml, 1 ml in ampoules № 10 | A11DA01 |
Undevit Undevit № 50 Dragee Active ingredient
Pharmacotherapeutic group Agents affecting the digestive system and metabolism |
№ 50 | A11BA |
Agents affecting blood system and hemapoiesis
Name | Dosage form | ATC code |
---|---|---|
Aquaferrol Aquaferrol 10 mg/ml, 125 ml № 1 Syrup Active ingredient
Pharmacotherapeutic group Agents affecting blood system and hemapoiesis |
10 mg/ml, 125 ml № 1 | В03АВ05 |
Cyanocobalamin (vitamin В12) Cyanocobalamin (vitamin В12) 0,5 mg/ml, 1 ml № 10 Solution for injections Active ingredient
Pharmacotherapeutic group Agents affecting blood system and hemapoiesis |
0,5 mg/ml, 1 ml № 10 | B03BA01 |
Ferrofol Ferrofol № 30 Chewable tablets Active ingredient
Pharmacotherapeutic group Agents affecting blood system and hemapoiesis |
№ 30 | В03АD04 |
Folic acid Folic acid 5 mg № 50 Tablets Active ingredient
Pharmacotherapeutic group Agents affecting blood system and hemapoiesis |
5 mg № 50 | B03BB01 |
Folic acid Folic acid 1 mg № 50 Tablets Active ingredient
Pharmacotherapeutic group Agents affecting blood system and hemapoiesis |
1 mg № 50 | B03BB01 |
Magnesium sulfate Magnesium sulfate 250 mg/ml, 5 ml № 10 Solution for injections Active ingredient
Pharmacotherapeutic group Agents affecting blood system and hemapoiesis |
250 mg/ml, 5 ml № 10 | B05XA05 |
Sodium chloride Sodium chloride 9 mg/ml, 5 ml №10 Solution for injections Active ingredient
Pharmacotherapeutic group Agents affecting blood system and hemapoiesis |
9 mg/ml, 5 ml №10 | B05XA03 |
Tranexamic acid Tranexamic acid 50 mg/ml, 5 ml № 5, № 10, № 100 Solution for injections Active ingredient
Pharmacotherapeutic group Agents affecting blood system and hemapoiesis |
50 mg/ml, 5 ml № 5, № 10, № 100 | B02AA02 |
Tranexamic acid Tranexamic acid 100 mg/ml, 5 ml № 5, № 10, № 100 Solution for injections Active ingredient
Pharmacotherapeutic group Agents affecting blood system and hemapoiesis |
100 mg/ml, 5 ml № 5, № 10, № 100 | B02AA02 |
Trombolik-Cardio Trombolik-Cardio 100 mg № 20 Enterosoluble tablets Active ingredient
Pharmacotherapeutic group Agents affecting blood system and hemapoiesis |
100 mg № 20 | B01AC06 |
Agents affecting cardio-vascular system
Name | Dosage form | ATC code |
---|---|---|
Accordin Accordin 100 mg/ml, 5 ml № 5, № 10, № 100 Solution for injections Active ingredient
Pharmacotherapeutic group Agents affecting cardio-vascular system |
100 mg/ml, 5 ml № 5, № 10, № 100 | С01ЕВ22 |
Amiodarone Amiodarone 0,2 g № 30 Tablets Active ingredient
Pharmacotherapeutic group Agents affecting cardio-vascular system |
0,2 g № 30 | C01BD01 |
Amlodipine Amlodipine 5 mg №60 Tablets Active ingredient
Pharmacotherapeutic group Agents affecting cardio-vascular system |
5 mg №60 | C08CA01 |
Amlodipine Amlodipine 5 mg №90 Tablets Active ingredient
Pharmacotherapeutic group Agents affecting cardio-vascular system |
5 mg №90 | C08CA01 |
Amlodipine Amlodipine 10 mg №60 Active ingredient
Pharmacotherapeutic group Agents affecting cardio-vascular system |
10 mg №60 | C08CA01 |
Amlodipine Amlodipine 10 mg №90 Active ingredient
Pharmacotherapeutic group Agents affecting cardio-vascular system |
10 mg №90 | C08CA01 |
Amlodipine Amlodipine 5 mg № 30 Tablets Active ingredient
Pharmacotherapeutic group Agents affecting cardio-vascular system |
5 mg № 30 | C08CA01 |
Amlodipine Amlodipine 10 mg № 30 Tablets Active ingredient
Pharmacotherapeutic group Agents affecting cardio-vascular system |
10 mg № 30 | C08CA01 |
Anaesthesolum Anaesthesolum № 5, № 10 Suppositories Active ingredient
Pharmacotherapeutic group Agents affecting cardio-vascular system |
№ 5, № 10 | C05AD |
Ascorutin Ascorutin № 50, № 800 Tablets Active ingredient
Pharmacotherapeutic group Agents affecting cardio-vascular system |
№ 50, № 800 | C05CA51 |
Beladonna Beladonna 0,015 g № 10 Rectal suppositories Active ingredient
Pharmacotherapeutic group Agents affecting cardio-vascular system |
0,015 g № 10 | C05AX |
Bethiolum Bethiolum № 10 Rectal suppositories Active ingredient
Pharmacotherapeutic group Agents affecting cardio-vascular system |
№ 10 | C05AX03 |
Corargin Corargin №50 №900 Film-coated tablets Active ingredient
Pharmacotherapeutic group Agents affecting cardio-vascular system |
№50 №900 | C01EX |
Enalapril Enalapril 0,01 g № 20 Tablets Active ingredient
Pharmacotherapeutic group Agents affecting cardio-vascular system |
0,01 g № 20 | C09AA02 |
Enalapril Enalapril 0,01 g № 90 Tablets Active ingredient
Pharmacotherapeutic group Agents affecting cardio-vascular system |
0,01 g № 90 | C09AA02 |
Enalapril Enalapril 0,01 g № 50 Tablets Active ingredient
Pharmacotherapeutic group Agents affecting cardio-vascular system |
0,01 g № 50 | C09AA02 |
Larginus Larginus 200 mg/ml Oral solution Active ingredient
Pharmacotherapeutic group Agents affecting cardio-vascular system |
100 мл | С01E |
Lekdona | 15 mg № 10 | C05AX |
Leksol | № 5, № 10 | C05AD |
Nicotinic acid Nicotinic acid 50 mg № 50 Tablets Active ingredient
Pharmacotherapeutic group Agents affecting cardio-vascular system |
50 mg № 50 | C04AC01 |
Nifedipine Nifedipine 20 mg № 50 Film-coated tablets Active ingredient
Pharmacotherapeutic group Agents affecting cardio-vascular system |
20 mg № 50 | C08CA05 |
Nifedipine Nifedipine 10 mg № 50 Film-coated tablets Active ingredient
Pharmacotherapeutic group Agents affecting cardio-vascular system |
10 mg № 50 | C08CA05 |
Nitroglycerine Nitroglycerine 0,5 mg № 40 Sublingual tablets Active ingredient
Pharmacotherapeutic group Agents affecting cardio-vascular system |
0,5 mg № 40 | C01DA02 |
Nitrogranulong Nitrogranulong 5,2 mg № 10, № 50 Prolonged release tablets Active ingredient
Pharmacotherapeutic group Agents affecting cardio-vascular system |
5,2 mg № 10, № 50 | C01DA02 |
Nitrogranulong Nitrogranulong 2,9 mg № 10, № 50 Prolonged release tablets Active ingredient
Pharmacotherapeutic group Agents affecting cardio-vascular system |
2,9 mg № 10, № 50 | C01DA02 |
Oftalek Oftalek 10 mg/ml 1 ml №10 Solution for injections Active ingredient
Pharmacotherapeutic group Agents affecting cardio-vascular system |
10 mg/ml 1 ml №10 | С05СX |
Pentoxifylline Pentoxifylline 100 mg № 10, № 50 Enterosoluble tablets Active ingredient
Pharmacotherapeutic group Agents affecting cardio-vascular system |
100 mg № 10, № 50 | C04AD03 |
Proctozol Proctozol № 5, № 10 Rectal suppositories Active ingredient
Pharmacotherapeutic group Agents affecting cardio-vascular system |
№ 5, № 10 | C05AD51 |
Propolis Propolis 0,1 g № 5, № 10 Suppositories Active ingredient
Pharmacotherapeutic group Agents affecting cardio-vascular system |
0,1 g № 5, № 10 | C05AX |
Riboxin Riboxin 200 mg № 10, № 50 Film-coated tablets Active ingredient
Pharmacotherapeutic group Agents affecting cardio-vascular system |
200 mg № 10, № 50 | C01EB |
Torasemide Torasemide 5 mg/ml 2 ml, 4 ml № 5, № 10, № 100 Solution for injections Active ingredient
Pharmacotherapeutic group Agents affecting cardio-vascular system |
5 mg/ml 2 ml, 4 ml № 5, № 10, № 100 | C03CA04 |
Dermatological agents
Name | Dosage form | ATC code |
---|---|---|
Aecol | 50 ml № 1 | D03AX |
Aecol | 50 ml, 100 ml | D03АX |
Aecol | 100 ml № 1 | D03AX |
Iodine Pechaevskiy Iodine Pechaevskiy 10 % 30 ml № 1 Solution for external administration Active ingredient
Pharmacotherapeutic group Dermatological agents |
10 % 30 ml № 1 | D08AG02 |
Iodine Pechaevskiy Iodine Pechaevskiy 10 % 120 ml № 1 Solution for external administration Active ingredient
Pharmacotherapeutic group Dermatological agents |
10 % 120 ml № 1 | D08AG02 |
Iodine Pechaevskiy Iodine Pechaevskiy 10 % 1000 ml № 1 Solution for external administration Active ingredient
Pharmacotherapeutic group Dermatological agents |
10 % 1000 ml № 1 | D08AG02 |
Naftiderile Naftiderile 10 ml № 1 Dermal solution Active ingredient
Pharmacotherapeutic group Dermatological agents |
10 ml № 1 | D01AE22 |
Agents affecting genitourinary system and reproductive hormones
Name | Dosage form | ATC code |
---|---|---|
Chinofucin Chinofucin 0,015 g № 5, № 10 Vaginal suppositories Active ingredient
Pharmacotherapeutic group Agents affecting genitourinary system and reproductive hormones |
0,015 g № 5, № 10 | G01AC03 |
Eucolec Eucolec 0,05 g № 5, № 10 Suppositories Active ingredient
Pharmacotherapeutic group Agents affecting genitourinary system and reproductive hormones |
0,05 g № 5, № 10 | G01AX |
Klioron Klioron 16 mg № 10 Vaginal suppositories Active ingredient
Pharmacotherapeutic group Agents affecting genitourinary system and reproductive hormones |
16 mg № 10 | G01AX |
Klioron V Klioron V 16 mg № 10 Pharmacotherapeutic group Agents affecting genitourinary system and reproductive hormones |
16 mg № 10 | G01AX |
Lekfucin Lekfucin 15 mg № 5, № 10 Active ingredient
Pharmacotherapeutic group Agents affecting genitourinary system and reproductive hormones |
15 mg № 5, № 10 | G01AС03 |
Leknazole Leknazole 150 mg № 3 Active ingredient
Pharmacotherapeutic group Agents affecting genitourinary system and reproductive hormones |
150 mg № 3 | G01АF05 |
Lekvolek Lekvolek 50 mg № 5, № 10 Pharmacotherapeutic group Agents affecting genitourinary system and reproductive hormones |
50 mg № 5, № 10 | G01AX |
Levoklek Levoklek 50 mg № 5, № 10 Active ingredient
Pharmacotherapeutic group Agents affecting genitourinary system and reproductive hormones |
50 mg № 5, № 10 | G01AX |
Omix Omix 0,4 mg № 10, № 30 Hard capsules Active ingredient
Pharmacotherapeutic group Agents affecting genitourinary system and reproductive hormones |
0,4 mg № 10, № 30 | G04CA02 |
Omix Omix 0.4 mg № 10, № 30 Active ingredient
Pharmacotherapeutic group Agents affecting genitourinary system and reproductive hormones |
0.4 mg № 10, № 30 | G04C A02 |
Potentiale Potentiale 100 mg №4 Film-coated tablets Active ingredient
Pharmacotherapeutic group Agents affecting genitourinary system and reproductive hormones |
100 mg №4 | G04BE03 |
Potentiale Potentiale 100 mg № 1 Film-coated tablets Active ingredient
Pharmacotherapeutic group Agents affecting genitourinary system and reproductive hormones |
100 mg № 1 | G04BE03 |
Potentiale Potentiale 50 mg № 1 Film-coated tablets Active ingredient
Pharmacotherapeutic group Agents affecting genitourinary system and reproductive hormones |
50 mg № 1 | G04BE03 |
Potentiale Potentiale 50 mg № 2 Film-coated tablets Active ingredient
Pharmacotherapeutic group Agents affecting genitourinary system and reproductive hormones |
50 mg № 2 | G04BE03 |
Potentiale Potentiale 50 mg №4 Film-coated tablets Active ingredient
Pharmacotherapeutic group Agents affecting genitourinary system and reproductive hormones |
50 mg №4 | G04BE03 |
Potentiale Potentiale 100 mg №2 Film-coated tablets Active ingredient
Pharmacotherapeutic group Agents affecting genitourinary system and reproductive hormones |
100 mg №2 | G04BE03 |
Povidin Povidin 0,3 g № 5, № 10 Vaginal suppositories Active ingredient
Pharmacotherapeutic group Agents affecting genitourinary system and reproductive hormones |
0,3 g № 5, № 10 | G01AX11 |
Prostan Prostan 5 mg № 10, № 30 Film-coated tablets Active ingredient
Pharmacotherapeutic group Agents affecting genitourinary system and reproductive hormones |
5 mg № 10, № 30 | G04CB01 |
Prostatilen Prostatilen 0,03 g № 10 Rectal suppositories Active ingredient
Pharmacotherapeutic group Agents affecting genitourinary system and reproductive hormones |
0,03 g № 10 | G04CX |
Prostatilen Prostatilen 2 ml № 5, № 10 Solution for injections Active ingredient
Pharmacotherapeutic group Agents affecting genitourinary system and reproductive hormones |
2 ml № 5, № 10 | G04СX |
Prostatilen Prostatilen 0,03 g №5 Rectal suppositories Active ingredient
Pharmacotherapeutic group Agents affecting genitourinary system and reproductive hormones |
0,03 g №5 | G04CX |
Prostatilen-Zinc Prostatilen-Zinc № 5 Rectal suppositories Active ingredient
Pharmacotherapeutic group Agents affecting genitourinary system and reproductive hormones |
№ 5 | G04CX |
Prostatilen-Zinc Prostatilen-Zinc №10 Rectal suppositories Active ingredient
Pharmacotherapeutic group Agents affecting genitourinary system and reproductive hormones |
№10 | G04CX |
Santekvin Santekvin 0,15 g № 3 Vaginal suppositories Active ingredient
Pharmacotherapeutic group Agents affecting genitourinary system and reproductive hormones |
0,15 g № 3 | G01AF05 |
Hormone drugs for systemic use
Name | Dosage form | ATC code |
---|---|---|
Bemedozon Bemedozon 4 mg/ml, 1 ml № 5, № 10, № 100 Solution for injections Active ingredient
Pharmacotherapeutic group Hormone drugs for systemic use |
4 mg/ml, 1 ml № 5, № 10, № 100 | Н02АВ01 |
Dexamethasone Dexamethasone 4 mg/ml, 1 ml № 5 Solution for injections Active ingredient
Pharmacotherapeutic group Hormone drugs for systemic use |
4 mg/ml, 1 ml № 5 | H02AB02 |
Lekthasone Lekthasone 4 mg/1 ml № 5, № 100 Active ingredient
Pharmacotherapeutic group Hormone drugs for systemic use |
4 mg/1 ml № 5, № 100 | H02AB02 |
Antimicrobial agents for systemic use
Name | Dosage form | ATC code |
---|---|---|
Aciclovir Aciclovir 0,2 g № 10, № 20 Tablets Active ingredient
Pharmacotherapeutic group Antimicrobial agents for systemic use |
0,2 g № 10, № 20 | J05AB01 |
Amicacin sulfate Amicacin sulfate 50 mg/ml, 2 ml № 1 Solution for injections Active ingredient
Pharmacotherapeutic group Antimicrobial agents for systemic use |
50 mg/ml, 2 ml № 1 | J01GB06 |
Amikacin sulfate Amikacin sulfate 250 mg/ml, 2 ml № 1 Solution for injections Active ingredient
Pharmacotherapeutic group Antimicrobial agents for systemic use |
250 mg/ml, 2 ml № 1 | J01GB06 |
Amikacin sulfate Amikacin sulfate 250 mg/ml, 4 ml № 1 Solution for injections Active ingredient
Pharmacotherapeutic group Antimicrobial agents for systemic use |
250 mg/ml, 4 ml № 1 | J01GB06 |
Cefazolin Cefazolin 1,0 g № 1 Powder for solution for injections Active ingredient
Pharmacotherapeutic group Antimicrobial agents for systemic use |
1,0 g № 1 | J01DB04 |
Cefazolin Cefazolin 1,0 g № 5 Powder for solution for injections Active ingredient
Pharmacotherapeutic group Antimicrobial agents for systemic use |
1,0 g № 5 | J01DB04 |
Cefazolin 1000 Cefazolin 1000 1,0 g № 1 Powder for solution for injections Active ingredient
Pharmacotherapeutic group Antimicrobial agents for systemic use |
1,0 g № 1 | J01DB04 |
Cefazolin 1000 Cefazolin 1000 1,0 g № 5 Powder for solution for injections Active ingredient
Pharmacotherapeutic group Antimicrobial agents for systemic use |
1,0 g № 5 | J01DB04 |
Cefazolin combi Cefazolin combi 0,5 g № 1, № 10, № 50 Powder for solution for injections Active ingredient
Pharmacotherapeutic group Antimicrobial agents for systemic use |
0,5 g № 1, № 10, № 50 | J01DB04 |
Cefepime Cefepime 1 g № 1 Powder for solution for injections Active ingredient
Pharmacotherapeutic group Antimicrobial agents for systemic use |
1 g № 1 | J01DE01 |
Cefepime with solvent Cefepime with solvent 1,0 г № 1 Powder for solution for injections Active ingredient
Pharmacotherapeutic group Antimicrobial agents for systemic use |
1,0 г № 1 | J01DE01 |
Cefotaxime Cefotaxime 1,0 g №1 Powder for solution for injections Active ingredient
Pharmacotherapeutic group Antimicrobial agents for systemic use |
1,0 g №1 | J01DD01 |
Cefotaxime Cefotaxime 1,0 g №50 Powder for solution for injections Active ingredient
Pharmacotherapeutic group Antimicrobial agents for systemic use |
1,0 g №50 | J01DD01 |
Cefotaxime Cefotaxime 1,0 g №5 Powder for solution for injections Active ingredient
Pharmacotherapeutic group Antimicrobial agents for systemic use |
1,0 g №5 | J01DD01 |
Cefotaxime Cefotaxime 1,0 g № 1 Powder for solution for injections Active ingredient
Pharmacotherapeutic group Antimicrobial agents for systemic use |
1,0 g № 1 | J01DD01 |
Cefotaxime Cefotaxime 1,0 g № 5 Powder for solution for injections Active ingredient
Pharmacotherapeutic group Antimicrobial agents for systemic use |
1,0 g № 5 | J01DD01 |
Cefotaxime + Water for injection Cefotaxime + Water for injection 1 vial and 1 ampoule Powder for solution for injections Active ingredient
Pharmacotherapeutic group Antimicrobial agents for systemic use |
1 vial and 1 ampoule | J01D D01 |
Ceftazidime Ceftazidime 1,0 g № 1, № 5, № 50 Powder for solution for injections Active ingredient
Pharmacotherapeutic group Antimicrobial agents for systemic use |
1,0 g № 1, № 5, № 50 | J01DD02 |
Ceftriaxone Ceftriaxone 1,0 g №1 Powder for solution for injections Active ingredient
Pharmacotherapeutic group Antimicrobial agents for systemic use |
1,0 g №1 | J01DD04 |
Ceftriaxone Ceftriaxone 1,0 g №5 Powder for solution for injections Active ingredient
Pharmacotherapeutic group Antimicrobial agents for systemic use |
1,0 g №5 | J01DD04 |
Ceftriaxone Ceftriaxone 1,0 g №50 Powder for solution for injections Active ingredient
Pharmacotherapeutic group Antimicrobial agents for systemic use |
1,0 g №50 | J01DD04 |
Ceftriaxone Ceftriaxone 1,0 g №50 Powder for solution for injections Active ingredient
Pharmacotherapeutic group Antimicrobial agents for systemic use |
1,0 g №50 | J01DD04 |
Ceftriaxone Ceftriaxone 1,0 g № 1 Solution for injections Active ingredient
Pharmacotherapeutic group Antimicrobial agents for systemic use |
1,0 g № 1 | J01DD04 |
Ceftriaxone Ceftriaxone 1,0 g № 5 Solution for injections Active ingredient
Pharmacotherapeutic group Antimicrobial agents for systemic use |
1,0 g № 5 | J01DD04 |
Ceftriaxone + Lidocaine Ceftriaxone + Lidocaine 1 vial and 1 ampoule Powder for solution for injections Active ingredient
Pharmacotherapeutic group Antimicrobial agents for systemic use |
1 vial and 1 ampoule | J01D D04 |
Ceftriaxone + Water for injection Ceftriaxone + Water for injection 1 vial and 1 ampoule Powder for solution for injections Active ingredient
Pharmacotherapeutic group Antimicrobial agents for systemic use |
1 vial and 1 ampoule | J01D D04 |
Ceftriaxone 500 Ceftriaxone 500 0,5 g № 1, № 10, № 50 Powder for solution for injections Active ingredient
Pharmacotherapeutic group Antimicrobial agents for systemic use |
0,5 g № 1, № 10, № 50 | J01D D04 |
Cefuroxime Cefuroxime 0,75 g №1 Powder for solution for injections Active ingredient
Pharmacotherapeutic group Antimicrobial agents for systemic use |
0,75 g №1 | J01DC02 |
Cefuroxime Cefuroxime 0,75 g №1 Powder for solution for injections Active ingredient
Pharmacotherapeutic group Antimicrobial agents for systemic use |
0,75 g №1 | J01DC02 |
Cefuroxime Cefuroxime 1,5 g №1 Powder for solution for injections Active ingredient
Pharmacotherapeutic group Antimicrobial agents for systemic use |
1,5 g №1 | J01DC02 |
Cefuroxime Cefuroxime 1,5 g № 1 Powder for solution for injections Active ingredient
Pharmacotherapeutic group Antimicrobial agents for systemic use |
1,5 g № 1 | J01DС02 |
Cefuroxime + Water for injection Cefuroxime + Water for injection 1 vial and 1 ampoule Powder for solution for injections Active ingredient
Pharmacotherapeutic group Antimicrobial agents for systemic use |
1 vial and 1 ampoule | J01D С02 |
Cilpen Cilpen 500 mg/500 mg № 10 Powder for solution for infusion Active ingredient
Pharmacotherapeutic group Antimicrobial agents for systemic use |
500 mg/500 mg № 10 | J01DH51 |
Cilpen Cilpen 500 mg/500 mg № 1 Powder for solution for infusion Active ingredient
Pharmacotherapeutic group Antimicrobial agents for systemic use |
500 mg/500 mg № 1 | J01DH51 |
Ciprofloxacin Ciprofloxacin 500 mg № 10 Film-coated tablets Active ingredient
Pharmacotherapeutic group Antimicrobial agents for systemic use |
500 mg № 10 | J01MA02 |
Ciprofloxacin Ciprofloxacin 250 mg № 10 Film-coated tablets Active ingredient
Pharmacotherapeutic group Antimicrobial agents for systemic use |
250 mg № 10 | J01MA02 |
Cycloserine Cycloserine 250 mg № 30 Hard capsules Active ingredient
Pharmacotherapeutic group Antimicrobial agents for systemic use |
250 mg № 30 | J04AВ01 |
Fluconazole Fluconazole 100 mg № 10 Film-coated tablets Active ingredient
Pharmacotherapeutic group Antimicrobial agents for systemic use |
100 mg № 10 | J02AC01 |
Fluconazole Fluconazole 150 mg № 1 Film-coated tablets Active ingredient
Pharmacotherapeutic group Antimicrobial agents for systemic use |
150 mg № 1 | J02AC01 |
Fluconazole Fluconazole 150 mg №2 Film-coated tablets Active ingredient
Pharmacotherapeutic group Antimicrobial agents for systemic use |
150 mg №2 | J02AC01 |
Fluconazole Fluconazole 50 mg № 10 Film-coated tablets Active ingredient
Pharmacotherapeutic group Antimicrobial agents for systemic use |
50 mg № 10 | J02AC02 |
Lamivudine Lamivudine 10 mg/ml, 240 ml № 1 Oral solution Active ingredient
Pharmacotherapeutic group Antimicrobial agents for systemic use |
10 mg/ml, 240 ml № 1 | J05А F05 |
Lamivudine Lamivudine 150 mg № 60 Film-coated tablets Active ingredient
Pharmacotherapeutic group Antimicrobial agents for systemic use |
150 mg № 60 | J05AF05 |
Lazivudine Lazivudine № 60 Film-coated tablets Active ingredient
Pharmacotherapeutic group Antimicrobial agents for systemic use |
№ 60 | J05AR01 |
Lekcef Lekcef 1,0 g № 1, № 5, № 50 Active ingredient
Pharmacotherapeutic group Antimicrobial agents for systemic use |
1,0 g № 1, № 5, № 50 | J01DD04 |
Lekcef + Water for injections Lekcef + Water for injections 1 vial and 1 ampoule Active ingredient
Pharmacotherapeutic group Antimicrobial agents for systemic use |
1 vial and 1 ampoule | J01DD04 |
Lekcin | 200 mg № 10 | J01MA01 |
Lekfazolin | 1,0 g № 1 | J01DB04 |
Lektaxime | 1.0 g № 1 | J01DD01 |
Lektaxime + Water for injection Lektaxime + Water for injection 1 vial and 1 ampoule Active ingredient
Pharmacotherapeutic group Antimicrobial agents for systemic use |
1 vial and 1 ampoule | J01DD01 |
Levofloxacin Levofloxacin 250 mg № 10 Film-coated tablets Active ingredient
Pharmacotherapeutic group Antimicrobial agents for systemic use |
250 mg № 10 | J01MA12 |
Levofloxacin Levofloxacin 500 mg № 10 Film-coated tablets Active ingredient
Pharmacotherapeutic group Antimicrobial agents for systemic use |
500 mg № 10 | J01MA12 |
Meropenem Meropenem 1,0 g №1 Powder for solution for injections Active ingredient
Pharmacotherapeutic group Antimicrobial agents for systemic use |
1,0 g №1 | J01DH02 |
Meropenem Meropenem 1,0 g № 1 Powder for solution for injections Active ingredient
Pharmacotherapeutic group Antimicrobial agents for systemic use |
1,0 g № 1 | J01DH02 |
Moxifloxacin Moxifloxacin 400 mg №5 Film-coated tablets Active ingredient
Pharmacotherapeutic group Antimicrobial agents for systemic use |
400 mg №5 | J01MA14 |
Moxifloxacin Moxifloxacin 400 мг №7 Film-coated tablets Active ingredient
Pharmacotherapeutic group Antimicrobial agents for systemic use |
400 мг №7 | J01MA14 |
Moxifloxacin Moxifloxacin 400 mg №10 Film-coated tablets Active ingredient
Pharmacotherapeutic group Antimicrobial agents for systemic use |
400 mg №10 | J01MA14 |
Nitroxoline Nitroxoline 50 mg № 10, № 50 Film-coated tablets Active ingredient
Pharmacotherapeutic group Antimicrobial agents for systemic use |
50 mg № 10, № 50 | J01XX07 |
Ofloxacin Ofloxacin 0,2 g № 10 Tablets Active ingredient
Pharmacotherapeutic group Antimicrobial agents for systemic use |
0,2 g № 10 | J01MA01 |
PAS-ISO PAS-ISO 100 g granules in bag № 1 Enterosoluble granules Active ingredient
Pharmacotherapeutic group Antimicrobial agents for systemic use |
100 g granules in bag № 1 | J04AM |
Promocef Promocef 1,0 g № 1, № 5 Powder for solution for injections Active ingredient
Pharmacotherapeutic group Antimicrobial agents for systemic use |
1,0 g № 1, № 5 | J01DD04 |
Protech Protech 250 mg № 50, № 500 Film-coated tablets Active ingredient
Pharmacotherapeutic group Antimicrobial agents for systemic use |
250 mg № 50, № 500 | J04AD01 |
Sodium aminosalicylate Sodium aminosalicylate 0,8 g/1g, 100 g № 1 Enterosoluble granules Pharmacotherapeutic group Antimicrobial agents for systemic use |
0,8 g/1g, 100 g № 1 | J04AA02 |
Terizidone Terizidone 250 mg № 10 Hard capsules Active ingredient
Pharmacotherapeutic group Antimicrobial agents for systemic use |
250 mg № 10 | J04AK03 |
Triseptol Triseptol 100 mg/20 mg № 20 Tablets Active ingredient
Pharmacotherapeutic group Antimicrobial agents for systemic use |
100 mg/20 mg № 20 | J01EE01 |
Triseptol Triseptol 400 mg/80 mg № 20 Tablets Active ingredient
Pharmacotherapeutic group Antimicrobial agents for systemic use |
400 mg/80 mg № 20 | J01EE01 |
Urosept Urosept 0,2 g № 10 Suppositories Active ingredient
Pharmacotherapeutic group Antimicrobial agents for systemic use |
0,2 g № 10 | J01MB04 |
Zidovudine Zidovudine 10 mg/ml 200 ml Oral solution Active ingredient
Pharmacotherapeutic group Antimicrobial agents for systemic use |
10 mg/ml 200 ml | J05AF01 |
Name | Dosage form | ATC code |
---|---|---|
Pemetrexed Pemetrexed 500 mg № 1 Lyophilisate solution for infusion Active ingredient
Pharmacotherapeutic groupAntineoplastic and immunomodulating agents |
500 mg № 1 | L01ВА04 |
Agents affecting musculo-skeletal system
Name | Dosage form | ATC code |
---|---|---|
Blockpain Blockpain 30 mg/ml, 1 ml №10 Solution for injections Active ingredient
Pharmacotherapeutic group Agents affecting musculo-skeletal system |
30 mg/ml, 1 ml №10 | M01AB15 |
Desket Desket 25 mg/ml, 2 ml № 10 Solution for injections Active ingredient
Pharmacotherapeutic group Agents affecting musculo-skeletal system |
25 mg/ml, 2 ml № 10 | M01AE17 |
Diclofenac Diclofenac 0,1 g № 10 Rectal suppositories Active ingredient
Pharmacotherapeutic group Agents affecting musculo-skeletal system |
0,1 g № 10 | M01AB05 |
Diclofenac Diclofenac 25 mg/ml, 3 ml №5 Solution for injections Active ingredient
Pharmacotherapeutic group Agents affecting musculo-skeletal system |
25 mg/ml, 3 ml №5 | M01AB05 |
Ibuprofen Ibuprofen 200 mg № 50 Film-coated tablets Active ingredient
Pharmacotherapeutic group Agents affecting musculo-skeletal system |
200 mg № 50 | M01AE01 |
Ibuprofen 200 Ibuprofen 200 200 mg № 10, № 50, № 900 Active ingredient
Pharmacotherapeutic group Agents affecting musculo-skeletal system |
200 mg № 10, № 50, № 900 | М01А Е01 |
Ibuprofen 400 Ibuprofen 400 400 mg № 10, №20, № 50 Active ingredient
Pharmacotherapeutic group Agents affecting musculo-skeletal system |
400 mg № 10, №20, № 50 | M01A E01 |
Ibuprofen 400 Ibuprofen 400 400 mg № 50 Film-coated tablets Active ingredient
Pharmacotherapeutic group Agents affecting musculo-skeletal system |
400 mg № 50 | М01АЕ01 |
Ibuprofen 400 Ibuprofen 400 400 mg №10 Film-coated tablets Active ingredient
Pharmacotherapeutic group Agents affecting musculo-skeletal system |
400 mg №10 | М01АЕ01 |
Ibuprofen 400 Ibuprofen 400 400 mg №20 Film-coated tablets Active ingredient
Pharmacotherapeutic group Agents affecting musculo-skeletal system |
400 mg №20 | М01АЕ01 |
Inflamine Inflamine 0,015 g № 10 Rectal suppositories Active ingredient
Pharmacotherapeutic group Agents affecting musculo-skeletal system |
0,015 g № 10 | M01AC06 |
Inflamine Inflamine 15 mg/1,5 ml in ampoule № 5 Solution for injections Active ingredient
Pharmacotherapeutic group Agents affecting musculo-skeletal system |
15 mg/1,5 ml in ampoule № 5 | М01АС06 |
Ketalgin Ketalgin 0,01 g, № 10 Tablets Active ingredient
Pharmacotherapeutic group Agents affecting musculo-skeletal system |
0,01 g, № 10 | M01AB15 |
Lekfenac | 100 mg № 10 | M01AB05 |
Lekfenac Lekfenac 75 mg/3 ml № 5, № 100 Active ingredient
Pharmacotherapeutic group Agents affecting musculo-skeletal system |
75 mg/3 ml № 5, № 100 | М01АВ05 |
Lektalgin Lektalgin 30 mg/ml 1 ml № 10, № 100 Active ingredient
Pharmacotherapeutic group Agents affecting musculo-skeletal system |
30 mg/ml 1 ml № 10, № 100 | M01AB15 |
Meloxicam Meloxicam 0,0075 g № 10 ,№ 20 Tablets Active ingredient
Pharmacotherapeutic group Agents affecting musculo-skeletal system |
0,0075 g № 10 ,№ 20 | M01AC06 |
Meloxicam Meloxicam 0,015 g № 10, № 20 Tablets Active ingredient
Pharmacotherapeutic group Agents affecting musculo-skeletal system |
0,015 g № 10, № 20 | M01AC06 |
Nimesulide Nimesulide 0,1 g № 10, № 30 Tablets Active ingredient
Pharmacotherapeutic group Agents affecting musculo-skeletal system |
0,1 g № 10, № 30 | M01AX17 |
Ortophen Ortophen 25 mg № 10, № 30 Enterosoluble tablets Active ingredient
Pharmacotherapeutic group Agents affecting musculo-skeletal system |
25 mg № 10, № 30 | M01AB05 |
Zoledronic acid Zoledronic acid 0,8 mg/ml, 5 ml № 1, № 5, № 10 Concentrate for solution for infusion Active ingredient
Pharmacotherapeutic group Agents affecting musculo-skeletal system |
0,8 mg/ml, 5 ml № 1, № 5, № 10 | М05ВА08 |
Agents affecting the nervous system
Name | Dosage form | ATC code |
---|---|---|
Acetylsalicylic acid Acetylsalicylic acid 500 mg № 10 Tablets Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
500 mg № 10 | N02BA01 |
Alzhmerat Alzhmerat 600 mg/7 ml № 10 Oral solution Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
600 mg/7 ml № 10 | N07A X02 |
Alzhmerat Alzhmerat 250 mg/ml, 4 ml № 5, № 10, № 100 Solution for injections Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
250 mg/ml, 4 ml № 5, № 10, № 100 | N07AX02 |
Amitriptylline Amitriptylline 25 mg № 50, № 1000 Film-coated tablets Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
25 mg № 50, № 1000 | N06AA09 |
Analgin Analgin 500 mg/ml, 2 ml № 10 Solution for injections Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
500 mg/ml, 2 ml № 10 | N02BB02 |
Analgin for children Analgin for children 0,1 g № 10 Rectal suppositories Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
0,1 g № 10 | N02BB02 |
Analgin for children Analgin for children 0,25 g № 10 Rectal suppositories Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
0,25 g № 10 | N02BB02 |
Azaleptol Azaleptol 100 mg №50 Tablets Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
100 mg №50 | N05AH02 |
Azaleptol Azaleptol 25 mg № 50 Tablets Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
25 mg № 50 | N05AH02 |
Barviton Barviton 5 mg/ml, 2 ml № 10 Solution for injections Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
5 mg/ml, 2 ml № 10 | N06BX18 |
Carbamazepine Carbamazepine 200 mg №20 Tablets Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
200 mg №20 | N03AF01 |
Carbamazepine Carbamazepine 200 mg № 50 Tablets Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
200 mg № 50 | N03AF01 |
Cilityn Cilityn 250 mg/ml, 4 ml № 5, № 10, № 100 Solution for injections Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
250 mg/ml, 4 ml № 5, № 10, № 100 | N06BX06 |
Cinnarizine Cinnarizine 0,025 g № 25, № 50 Tablets Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
0,025 g № 25, № 50 | N07CA02 |
Cylityne Cylityne 100 mg, 30 ml Oral solution Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
100 mg, 30 ml | N06BX06 |
Epigaba Epigaba 300 mg №100 Hard capsules Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
300 mg №100 | N03AX12 |
Epigaba Epigaba 300 mg № 20 Hard capsules Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
300 mg № 20 | N03AX12 |
Ipidacord Ipidacord 15 mg/ml 1 ml №10 Solution for injections Pharmacotherapeutic group Agents affecting the nervous system |
15 mg/ml 1 ml №10 | N07АА |
Ipidacord Ipidacord 5 mg/ml 1 ml №10, №100 Solution for injections Pharmacotherapeutic group Agents affecting the nervous system |
5 mg/ml 1 ml №10, №100 | N07АА |
Leknizine Leknizine 0,025 g № 10, № 50 Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
0,025 g № 10, № 50 | N07CA02 |
Lektil 200 | 200 mg №50 | N03A F01 |
Lidocaine Lidocaine 20 mg/ml, 2 ml in ampoules № 10 Solution for injections Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
20 mg/ml, 2 ml in ampoules № 10 | N01BB02 |
Lidocaine Lidocaine 10 mg/ml, 3,5 ml № 10 Solution for injections Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
10 mg/ml, 3,5 ml № 10 | N01BВ02 |
Nalbuphine Nalbuphine 10 mg/ml 1 ml №10 Solution for injections Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
10 mg/ml 1 ml №10 | N02AF02 |
Nalbuphine Nalbuphine 10 mg/ml 2 ml №5 Solution for injections Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
10 mg/ml 2 ml №5 | N02AF02 |
Novocaine Novocaine 5 mg/ml, 5 ml № 10 Solution for injections Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
5 mg/ml, 5 ml № 10 | N01BA02 |
Paracetamol Paracetamol 500 mg №10, №20, №50 Tablets Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
500 mg №10, №20, №50 | N02B E01 |
Piracetam Piracetam 200 mg/mg, 5 ml № 10 Solution for injections Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
200 mg/mg, 5 ml № 10 | N06BX03 |
Pregalon 150 | 150 мг №14 | N03A X16 |
Pregalon 150 | 150 mg №21 | N03A X16 |
Pregalon 300 | 300 мг №14 | N03A X16 |
Pregalon 300 | 300 mg №21 | N03A X16 |
Pregalon 75 | 75 мг №14 | N03A X16 |
Pregalon 75 | 75 mg №21 | N03A X16 |
Tet 36.6 RAPID with acacia flavour Tet 36.6 RAPID with acacia flavour 23 g № 5, № 10 Powder for oral solution Pharmacotherapeutic group Agents affecting the nervous system |
23 g № 5, № 10 | N02BЕ51 |
Tet 36.6 RAPID with lemon flavour Tet 36.6 RAPID with lemon flavour 23 g № 5, № 10 Powder for oral solution Pharmacotherapeutic group Agents affecting the nervous system |
23 g № 5, № 10 | N02BЕ51 |
Tеt 36.6 MAXI with lemon flavour Tеt 36.6 MAXI with lemon flavour 23 g № 5, № 10 Powder for oral solution Pharmacotherapeutic group Agents affecting the nervous system |
23 g № 5, № 10 | N02BЕ51 |
Tеt 36.6 MAXI with raspberry flavour Tеt 36.6 MAXI with raspberry flavour 23 g № 5, № 10 Powder for oral solution Pharmacotherapeutic group Agents affecting the nervous system |
23 g № 5, № 10 | N02BE51 |
Tеt 36.6 with acacia flavour Tеt 36.6 with acacia flavour 13,1 g № 5, № 10 Powder for oral solution Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
13,1 g № 5, № 10 | N02BE51 |
Venocor Venocor 50 mg/ml 2 ml № 10 Solution for injections Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
50 mg/ml 2 ml № 10 | N07XX |
Venocor Venocor 50 mg/ml, 5 ml № 5 Solution for injections Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
50 mg/ml, 5 ml № 5 | N07XX |
Vinpocetin Vinpocetin 0,005 g № 30, № 50 Tablets Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
0,005 g № 30, № 50 | N06BX18 |
Anti-parasite agents, insecticides and repellents
Name | Dosage form | ATC code |
---|---|---|
PerMin PerMin 50 g Solution for external administration Active ingredient
Pharmacotherapeutic group Anti-parasite agents, insecticides and repellents |
50 g | - |
PerMin NEW PerMin NEW 50 ml Solution for external administration Active ingredient
Pharmacotherapeutic group Anti-parasite agents, insecticides and repellents |
50 ml | - |
Agents affecting the respiratory system
Name | Dosage form | ATC code |
---|---|---|
Alergolik Alergolik 5 mg № 10 Film-coated tablets Active ingredient
Pharmacotherapeutic group Agents affecting the respiratory system |
5 mg № 10 | R06AE09 |
Alergolik Alergolik 5 mg/ml, 10 ml № 1 Oral drops Active ingredient
Pharmacotherapeutic group Agents affecting the respiratory system |
5 mg/ml, 10 ml № 1 | R06AE09 |
Alergolik Alergolik 5 mg № 30 Film-coated tablets Active ingredient
Pharmacotherapeutic group Agents affecting the respiratory system |
5 mg № 30 | R06AE09 |
Ambroxol Ambroxol 0,03 g № 10, № 20, № 50, № 100 Tablets Active ingredient
Pharmacotherapeutic group Agents affecting the respiratory system |
0,03 g № 10, № 20, № 50, № 100 | R05CB06 |
Desloratadine Desloratadine 0,5 mg/ml, 60 ml № 1 Syrup Active ingredient
Pharmacotherapeutic group Agents affecting the respiratory system |
0,5 mg/ml, 60 ml № 1 | R06AX27 |
Desloratadine Desloratadine 5 mg № 10, № 30 Film-coated tablets Active ingredient
Pharmacotherapeutic group Agents affecting the respiratory system |
5 mg № 10, № 30 | R06AX27 |
Ketotifen Ketotifen 0,001 g № 10 Tablets Active ingredient
Pharmacotherapeutic group Agents affecting the respiratory system |
0,001 g № 10 | R06AX17 |
Ketotifen Ketotifen 0,001 g № 30 Tablets Active ingredient
Pharmacotherapeutic group Agents affecting the respiratory system |
0,001 g № 30 | R06AX17 |
Loratadine Loratadine 0,01 g № 20 Tablets Active ingredient
Pharmacotherapeutic group Agents affecting the respiratory system |
0,01 g № 20 | R06AX13 |
Loratadine Loratadine 0,01 g № 10 Tablets Active ingredient
Pharmacotherapeutic group Agents affecting the respiratory system |
0,01 g № 10 | R06AX13 |
Lorolik Lorolik 50 ml Oral spray Active ingredient
Pharmacotherapeutic group Agents affecting the respiratory system |
50 ml | R02AA20 |
Lorolik Lorolik 125 ml Solution for oral cavity Active ingredient
Pharmacotherapeutic group Agents affecting the respiratory system |
125 ml | R02AA20 |
Mucolik Mucolik 2%, 125 ml Syrup Active ingredient
Pharmacotherapeutic group Agents affecting the respiratory system |
2%, 125 ml | R05CB03 |
Mucolik Mucolik 5%, 125 ml Syrup Active ingredient
Pharmacotherapeutic group Agents affecting the respiratory system |
5%, 125 ml | R05СВ03 |
Mucosol Mucosol 7,5 мг/мл 2 ml №10 Solution for infusions Active ingredient
Pharmacotherapeutic group Agents affecting the respiratory system |
7,5 мг/мл 2 ml №10 | R05C B06 |
Mucosol Mucosol 7,5 мг/мл 2 ml №5 Solution for infusions Active ingredient
Pharmacotherapeutic group Agents affecting the respiratory system |
7,5 мг/мл 2 ml №5 | R05CB06 |
Suprostilin Suprostilin 0,025 g № 10, № 20 Tablets Active ingredient
Pharmacotherapeutic group Agents affecting the respiratory system |
0,025 g № 10, № 20 | R06AC03 |
Miscellaneous agents
Name | Dosage form | ATC code |
---|---|---|
Calcium folinate Calcium folinate 10 mg/ml 5 ml № 5 Solution for injections Active ingredient
Pharmacotherapeutic group Miscellaneous agents |
10 mg/ml 5 ml № 5 | V03AF03 |
Water for injections Water for injections 2 ml № 10 Solvent for parenteral administration Active ingredient
Pharmacotherapeutic group Miscellaneous agents |
2 ml № 10 | V07AB |
Water for injections Water for injections 5 ml № 10 Solvent for parenteral administration Active ingredient
Pharmacotherapeutic group Miscellaneous agents |
5 ml № 10 | V07AB |
Name | Dosage form | ATC code |
---|---|---|
AllSept AllSept 500 ml, 1000 ml, 5000 ml Solution for external administration Active ingredient
Pharmacotherapeutic groupHealthcare Products
|
500 ml, 1000 ml, 5000 ml | |
AllSept 75 AllSept 75 50 ml Solution for external administration Active ingredient
Pharmacotherapeutic groupHealthcare Products
|
50 ml | |
Bifolac Bifolac № 5, № 10 Vaginal suppositories Active ingredient
Pharmacotherapeutic groupHealthcare Products
|
№ 5, № 10 | - |
Fitoprost Fitoprost № 5, № 10 Rectal suppositories Active ingredient
Pharmacotherapeutic groupHealthcare Products
|
№ 5, № 10 | - |
L-carnitine | 100 ml | - |
Lactovag Lactovag № 5, № 10 Vaginal suppositories Active ingredient
Pharmacotherapeutic groupHealthcare Products
|
№ 5, № 10 | - |
Lakarne | 10 ml, 100 ml | - |
Oblepiol Oblepiol 1,4 g 2,4 g № 5, № 10 Suppositories Active ingredient
Pharmacotherapeutic groupHealthcare Products
|
1,4 g 2,4 g № 5, № 10 | |
Saccharin-T | 50 tablets, 0,1 g | - |
SanteFem SanteFem № 10, № 14 Vaginal suppositories Active ingredient
Pharmacotherapeutic groupHealthcare Products
|
№ 10, № 14 | - |
Tablets Pechaevskie | with raspberry taste | - |
Tablets Pechaevskie | with mint taste | - |
Tablets Pechaevskie | with forest berry taste | - |
Tablets Pechaevskie | with tangerine taste | - |
Tablets Pechaevskie | with no-sugar contains | - |